Explore the full record of transactions filed by REESE DAVID M, Vice-Président Exécutif, Recherche et Développement. Officer active across 1 companies, notably AMGEN INC. Cumulatively, 9 filings have been published. The latest transaction was filed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
David M. Reese is the EVP, Research and Development at AMGEN INC. In this role, he is responsible for leading the company's research and development initiatives. David brings scientific and strategic expertise, thereby contributing to innovation and advancing research projects.